Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations and Comprehensive Loss (Unaudited)

v3.21.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Oct. 31, 2021
Oct. 31, 2020
Oct. 31, 2021
Oct. 31, 2020
OPERATING EXPENSES        
Research and development $ 1,750,050 $ 474,913 $ 2,666,458 $ 783,759
General and administrative 1,833,884 823,033 3,223,715 1,832,494
   Total operating expenses 3,583,934 1,297,946 5,890,173 2,616,253
Loss from operations (3,583,934) (1,297,946) (5,890,173) (2,616,253)
OTHER EXPENSE, NET        
Interest expense (15,995) (50,664) (29,623) (50,815)
Interest expense - related party (5,487) (5,487)
Interest income - related party 1,706
Total other expense, net (15,995) (56,151) (29,623) (54,596)
NET LOSS $ (3,599,929) $ (1,354,097) $ (5,919,796) $ (2,670,849)
Basic and diluted net loss per common share $ (0.04) $ (0.02) $ (0.07) $ (0.04)
Basic and diluted weighted average common        
shares outstanding 93,458,556 72,262,858 88,148,524 72,262,858